Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 7.22 0.21 (3%) Market Cap: 959.04 Mil Enterprise Value: 932.14 Mil PE Ratio: 0 PB Ratio: 2.33 GF Score: 82/100

Maravai LifeSciences Holdings Inc To Host R&D Day Transcript

Sep 28, 2023 / 02:00PM GMT
Release Date Price: $9.6 (-1.64%)
Debra Hart
Maravai LifeSciences Holdings, Inc. - Senior Director of IR

(technical difficulty) Maravai LifeSciences Investor R&D Day. We're really happy to have you here with us in New York, and to those of you online, welcome. I would like to first introduce myself. I'm Deb Hart. I lead Investor Relations for Maravai. I think I've met most of you.

I also want to point you to our disclaimers. We will be making forward-looking statements today, so please refer to our risk factors in our SEC filings. We also might refer to EBITDA figures. So we have reconciliations to any historic EBITDA on our press releases.

We have an outstanding lineup for you today. Starting off with Trey Martin, who's our newly appointed CEO as of about 9 weeks ago. He's going to introduce the company. He's followed by Dr. Kate Broderick, who leads our innovation team, Chief Innovation Officer, and she'll talk about our customer-focused innovation road map. After Kate, we have leaders of our Nucleic Acid Production team. Drew Burch is our General Manager, Executive Vice President of Nucleic Acid Products. He'll

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot